Tanvex BioPharma, Inc. (TPE:6541)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
63.30
-0.30 (-0.47%)
Apr 2, 2025, 1:30 PM CST

Tanvex BioPharma Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
376.96380.75786.232,2232,069
Upgrade
Cash & Short-Term Investments
376.96380.75786.232,2232,069
Upgrade
Cash Growth
-1.00%-51.57%-64.63%7.46%-14.78%
Upgrade
Accounts Receivable
0.079.40.332.52-
Upgrade
Other Receivables
31.5827.4327.3625.3125.57
Upgrade
Receivables
31.6536.8327.6927.8425.57
Upgrade
Inventory
217.84108.29170.8490.3350.08
Upgrade
Prepaid Expenses
49.1878.3558.9560.85119.25
Upgrade
Total Current Assets
675.62604.211,0442,4022,264
Upgrade
Property, Plant & Equipment
1,8271,9282,1512,1141,906
Upgrade
Other Intangible Assets
7.073.3812.0710.1711.96
Upgrade
Other Long-Term Assets
225.3227.67213.47187.58190.98
Upgrade
Total Assets
2,7352,7633,4204,7144,373
Upgrade
Accrued Expenses
134.27-115.93137.49210.99
Upgrade
Current Portion of Long-Term Debt
----54.77
Upgrade
Current Portion of Leases
160.01163.45124.6588.7565.74
Upgrade
Current Unearned Revenue
11.116.9128.07--
Upgrade
Other Current Liabilities
42.75193.3834.6322.2821.6
Upgrade
Total Current Liabilities
348.14363.73303.29248.51353.1
Upgrade
Long-Term Debt
----35.53
Upgrade
Long-Term Leases
1,4881,5681,7151,6701,363
Upgrade
Long-Term Unearned Revenue
5.4710.23---
Upgrade
Other Long-Term Liabilities
--10.47--
Upgrade
Total Liabilities
1,8421,9422,0281,9191,752
Upgrade
Common Stock
1,6411,3403,5273,5253,116
Upgrade
Additional Paid-In Capital
13,56712,43111,06110,9889,653
Upgrade
Retained Earnings
-14,136-12,755-12,969-11,327-9,784
Upgrade
Comprehensive Income & Other
-177.94-194.17-227.09-390.12-364.04
Upgrade
Shareholders' Equity
893.31821.111,3912,7952,621
Upgrade
Total Liabilities & Equity
2,7352,7633,4204,7144,373
Upgrade
Total Debt
1,6481,7321,8391,7591,519
Upgrade
Net Cash (Debt)
-1,271-1,351-1,053463.95549.19
Upgrade
Net Cash Growth
----15.52%-73.66%
Upgrade
Net Cash Per Share
-8.19-10.48-8.954.276.14
Upgrade
Filing Date Shares Outstanding
164.07133.96117.64117.57103.95
Upgrade
Total Common Shares Outstanding
164.07133.96117.64117.57103.95
Upgrade
Working Capital
327.48240.48740.432,1531,910
Upgrade
Book Value Per Share
5.446.1311.8323.7725.21
Upgrade
Tangible Book Value
886.24817.731,3792,7852,609
Upgrade
Tangible Book Value Per Share
5.406.1011.7323.6825.10
Upgrade
Machinery
1,089982.54975.18889.53884.87
Upgrade
Construction In Progress
44.3483.7172.8253.848.78
Upgrade
Leasehold Improvements
509.94415.69388.62318.95322.42
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.